The real cost of counterfeit medicines

被引：8
|
作者：
Burki, Talha
机构：
来源：
LANCET INFECTIOUS DISEASES | 2010年 / 10卷 / 09期
关键词：
D O I：
10.1016/S1473-3099(10)70173-0
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：585 / 586
页数：2
相关论文
共 50 条
  • [21] ICN surveys nurses on counterfeit medicines
    不详
    INTERNATIONAL NURSING REVIEW, 2006, 53 (04) : 245 - 245
  • [22] COUNTERFEIT MEDICINES - GLOBAL PROBLEM AND CHALENGE
    Haxhiu, Arlinda
    Trajkovic-Jolevska, Suzana
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (01) : 208 - 209
  • [23] China cracks down on counterfeit medicines
    Tomlinson, R
    BRITISH MEDICAL JOURNAL, 1999, 318 (7184): : 624 - 624
  • [24] Reliable low-cost capillary electrophoresis device for drug quality control and counterfeit medicines
    Marini, R. D.
    Rozet, E.
    Montes, M. L. A.
    Rohrbasser, C.
    Roht, S.
    Rheme, D.
    Bonnabry, P.
    Schappler, J.
    Veuthey, J. -L.
    Hubert, Ph
    Rudaz, S.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 53 (05) : 1278 - 1287
  • [25] Counterfeit medicines and substandard medicines: Different problems requiring different solutions
    't Hoen, Ellen
    Pascual, Fernando
    JOURNAL OF PUBLIC HEALTH POLICY, 2015, 36 (04) : 384 - 389
  • [26] I (Don't) want to consume counterfeit medicines: exploratory study on the antecedents of consumer attitudes toward counterfeit medicines
    Ofori-Parku, Sylvester Senyo
    Park, Sung Eun
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [27] I (Don’t) want to consume counterfeit medicines: exploratory study on the antecedents of consumer attitudes toward counterfeit medicines
    Sylvester Senyo Ofori-Parku
    Sung Eun Park
    BMC Public Health, 22
  • [28] The role of German official medicines control laboratories in combating counterfeit medicines
    Wiegard, Andrea
    Heuermann, Matthias
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2017, 60 (11) : 1214 - 1220
  • [29] With serialization solutions against Counterfeit Medicines proceed
    Manz, Juergen
    PHARMAZEUTISCHE INDUSTRIE, 2011, 73 (04): : 784 - 788
  • [30] Counterfeit Medicines: Problems, Risks, Possible Safeguards
    Piotrowiaki, Ralf
    Rabe, Klaus
    Mehnert, Joerg
    PHARMAZEUTISCHE INDUSTRIE, 2012, 74 (07): : 1172 - 1179
12345